Neurology Devices Market To Reach $37.5 Billion by 2035

Neurology devices market was valued at $18.9 billion in 2025 and is expected to grow to $37.5 billion by 2035, reflecting a CAGR of 7.2% over the forecast period (2026-2035). This growth is driven by rising prevalence of neurological disorders such as stroke, Parkinson’s disease, epilepsy, and Alzheimer’s, combined with increasing adoption of advanced neurotechnologies in hospitals and specialty clinics. According to the World Health Organization (WHO), approximately 15 million people worldwide suffer a stroke annually, with 5 million left permanently disabled, driving demand for neurosurgical and neurostimulation devices in acute and rehabilitative care. Among product types, Neurostimulation Devices are seeing the fastest adoption, driven by innovations in deep brain stimulation (DBS), spinal cord stimulation (SCS), and vagus nerve stimulation (VNS). These devices are increasingly used for epilepsy, Parkinson’s disease, and chronic pain, with the U.S. Food and Drug Administration (FDA) reporting more than 100,000 DBS implantations worldwide by 2024, indicating strong market traction.

Browse the full report description of “Neurology Devices Market Size, Share & Trends Analysis Report, By Product Type (Neurostimulation Devices, Neurosurgical Devices, Interventional Neurology Devices), By Application (Stroke, Parkinson’s Disease, Epilepsy), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/neurology-devices-market

Recent developments in the neurology devices space from 2022 to 2026 illustrate strong strategic moves by market players:

• In December 2025, Medtronic expanded its neurostimulation portfolio with next-generation DBS systems to enhance treatment precision for movement disorders.

• In May 2025, Natus Medical Incorporated announced the launch of BrainWatch, a wearable, wireless point-of-care EEG system designed for rapid deployment in emergency rooms and ICUs. The device integrates with the NeuroWorks platform, enabling remote neurologist collaboration and real-time seizure detection using FDA-cleared algorithms. BrainWatch can be set up in under five minutes, improving access to neurological monitoring and supporting faster clinical decision-making in critical care settings.

Market Coverage

• The market number available for – 2025-2035
  • Base year- 2025
  • Forecast period- 2026-2035
  • Segment Covered-
  o product Type
  o Application
  o End-User

Competitive Landscape – Medtronic, Abbott Laboratories, Boston Scientific, Stryker Corporation, Johnson & Johnson, among others.

Key questions addressed by the report

• What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • Who is the leader in the market?
  • How are players addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Neurology Devices Market Report Segment

By Product Type

• Neurostimulation Devices
• Neurosurgical Devices
• Interventional Neurology Devices
• CSF Management Devices
• Monitoring & Diagnostic Devices

By Application

• Stroke
• Parkinson’s Disease
• Epilepsy
• Chronic Pain
• Alzheimer’s Disease

By End-User

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Research Institutes

Global Neurology Devices Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/neurology-devices-market